Singulair
Product Images NDC 54868-4630

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Singulair (NDC 54868-4630). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (Tablets)

Packaging label for SINGULAIR 10 mg tablets distributed by Physicians Total Care, Inc. The label includes the NDC number 54868-3283-1, indicates a quantity of 30 tablets, and features a lot number and expiration date. Manufactured by Merck & Company, Inc., Whitehouse Station, NJ.*

FDA Label Image

Principal Display Panel (Chewable Tablets)

Label for SINGULAIR 4MG chewable tablets distributed by Physicians Total Care, Inc., Tulsa, OK. The label shows the product name, strength, dosage form, quantity (30 tablets), a lot number, expiration date, and manufacturer Merck & Company, Inc., Whitehouse Station, NJ, along with a barcode and NDC code 54868-4630-0.*

FDA Label Image

Principal Display Panel (Chewable Tablets)

SINGULAIR 5mg chewable tablet label showing distribution by Physicians Total Care, Inc. in Tulsa, OK. The label includes the NDC 54868-4847-0, lot number, expiration date, and manufacturing by Merck & Company, Inc. The package contains 30 tablets. A barcode and numeric code are also visible.*

FDA Label Image

Image Of Figure 1 (53b7439e F65d 401b 8267 79a1e6be2895 01)

A line graph depicting change in height (cm) over weeks on treatment comparing SINGULAIR 5 mg, Beclomethasone 336 mcg, and placebo groups over approximately 58 weeks. The graph shows growth trends with standard error noted as too small to display for the treatment group.*

FDA Label Image

Image Of Montelukast Sodium Chemical Structure (53b7439e F65d 401b 8267 79a1e6be2895 02)

Chemical structure diagram showing the molecular structure of Montelukast sodium, the active ingredient in SINGULAIR. The diagram includes atomic symbols and bonds illustrating the compound's chemical arrangement.*

FDA Label Image

Image Of Figure 2 (53b7439e F65d 401b 8267 79a1e6be2895 03)

A line graph comparing mean percent change from baseline over weeks in treatment between SINGULAIR and placebo groups. The x-axis represents weeks in treatment (0 to 15), and the y-axis shows mean percent change. Data points for both SINGULAIR and placebo are plotted with error bars.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.